Belmont Global Advisors’s Fortress Biotech FBIO Stock Holding History

Belmont Global Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.62M	Sell	36,333 -334	-0.9%	-$14.2K	1.53%	8
2016 Q2	$1.48M	Sell	36,667 -4,000	-10%	-$186K	1.42%	10
2016 Q1	$1.89M	Buy	40,667 +15,147	+59%	+$639K	1.92%	14
2015 Q4	$1.07M	Sell	25,520 -14,480	-36%	-$607K	1.38%	18
2015 Q3	$1.56M	Sell	40,000 -12,087	-23%	-$565K	2.65%	7
2015 Q2	$2.63M	Buy	52,087 +23,754	+84%	+$1.22M	2.91%	4
2015 Q1	$1.64M	Buy	+28,333	New	+$1.18M	1.66%	16
2014 Q4	–	Sell	-667	Closed	-$21K	–	118
2014 Q3	$21K	Buy	+667	New	+$17.7K	0.02%	122

Other funds holding FBIO

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Belmont Global Advisors's FBIO Position: Q3 2016 in Review

Belmont Global Advisors reduced its Fortress Biotech (FBIO) stake by 0.91% in Q3 2016, selling an estimated $14.2K and leaving 36,333 shares worth $1.62M. The position accounts for 1.53% of the portfolio, ranked #8.

Belmont Global Advisors first reported a position in FBIO in Q3 2014 and has held it in 8 quarters since. The position peaked at $2.63M in Q2 2015. 50 funds tracked by Wall St. Rank hold FBIO as of Q3 2016.

Belmont Global Advisors held 36,333 shares of Fortress Biotech worth $1.62M as of Q3 2016.
Belmont Global Advisors sold 334 Fortress Biotech shares in Q3 2016, an estimated $14.2K.
Fortress Biotech made up 1.53% of Belmont Global Advisors's portfolio in Q3 2016, its #8 holding.
Belmont Global Advisors first reported a position in Fortress Biotech in Q3 2014 and has held it in 8 quarters since.
Belmont Global Advisors's Fortress Biotech position peaked at $2.63M in Q2 2015.
50 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2016.

Based on Belmont Global Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.